Bayer Corporation, the U.S. division of global pharmaceutical giant, Bayer AG, employs some 16,300 people in the United States and generates $4.8 billion a year. For more than 150 years, the name “Bayer” has been associated with preventing and curing disease as well as with the alleviation of pain.
Focused on improving the quality of life by working in the fields of healthcare and agriculture, Bayer develops new molecules for use in innovative products and solutions, and focuses its research and development activities on understanding the biochemical processes in living organisms—humans, animals, and plants.
Because of Continuant’s track record of service and cost-savings, Bayer Corporation selected Continuant to help serve as the bridge company during the planned transition. With Continuant’s help, Bayer’s 58 systems in more than 20 different states across the country lived long enough to see through the transition. Along with that, Continuant also helped deploy new Cisco systems in at least 4 locations.
For a while, Bayer relied on its legacy Avaya and Siemens systems, but as time went on, these legacy systems came dangerously close to end of life. The company knew it needed—and wanted its old technology replaced with a new solution, but it didn’t have the proper insight to make this transition without spending far too much time and money. Bayer needed a partner that could help manage this change and keep its system alive for as long as possible.
Both during and after Bayer’s big transition, Continuant has served as “additional hands” on-site, making sure the company gets the best value it can for this wise investment.
Let’s develop a powerful business case for bringing Continuant to your organization.